Published in Immunology on April 01, 1987
14C1, an antigen associated with human ovarian cancer, defined using a human IgG monoclonal antibody. Clin Exp Immunol (1991) 0.81
Rate of incorporation of radiolabelled nucleosides does not necessarily reflect the metabolic state of cells in culture: effects of latent mycoplasma contamination. Immunology (1988) 0.79
Replacement of T-cell function by a T-cell product. Nat New Biol (1972) 5.20
Expression of human B cell-associated antigens on leukemias and lymphomas: a model of human B cell differentiation. Blood (1984) 2.74
Separate signals for human B cell proliferation and differentiation in response to Staphylococcus aureus: evidence for a two-signal model of B cell activation. J Immunol (1982) 2.48
T cell-replacing factor- (TRF) induced IgG secretion in a human B blastoid cell line and demonstration of acceptors for TRF. J Immunol (1981) 2.46
Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature (1980) 2.08
Markers of neoplastic transformation in epithelial cell lines derived from human carcinomas. J Natl Cancer Inst (1977) 2.07
H-2-unrestricted polyclonal maturation without replication of small B cells induced by antigen-activated T cell help factors. Eur J Immunol (1980) 1.77
3,3',5,5' - Tetramethylbenzidine as an Ames test negative chromogen for horse-radish peroxidase in enzyme-immunoassay. J Immunoassay (1981) 1.75
Purification to homogeneity of a high molecular weight human B cell growth factor; demonstration of specific binding to activated B cells; and development of a monoclonal antibody to the factor. J Exp Med (1985) 1.47
Soluble factors involved in B cell differentiation: identification of two distinct T cell-replacing factors (TRF). J Immunol (1983) 1.46
Regulation of antibody response in vitro. VII. Enhancing soluble factors for IgG and IgE antibody response. J Immunol (1973) 1.41
A "lymphokine-like" soluble product that induces proliferation and maturation of B cells appears in the serum-free supernatant of a T cell hybridoma as a consequence of mycoplasmal contamination. J Immunol (1985) 1.03
B cell growth and differentiation induced by supernatants of transformed epithelial cell lines. Eur J Immunol (1986) 1.03
Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate. Eur J Immunol (1983) 1.03
B cell maturation factor: effects on various cell populations. J Immunol (1984) 1.01
Human B cell responsiveness to B cell growth factor after activation by phorbol ester and monoclonal anti-mu antibody. J Immunol (1985) 0.99
Development of a human T-cell hybridoma secreting separate B-cell growth and differentiation factors. Proc Natl Acad Sci U S A (1984) 0.97
Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Immunology (1986) 0.90
The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor. Immunology (1987) 0.87
M4HS2, a new human T-cell line for the efficient generation of human T-cell hybrids. J Immunol Methods (1986) 0.85
Mitogenic response of neoplastic B cells: comparison of reactivity to Staphylococcus aureus Cowan I and anti-immunoglobulin antibodies. Clin Exp Immunol (1986) 0.85
Cytochemical comparison of immunologically characterized human leukaemia/lymphoma cell lines representing different levels of maturation. Br J Cancer (1983) 0.84
Cell marker studies in patients with newly diagnosed chronic lymphatic leukaemia. Scand J Haematol (1983) 0.81
Proliferation of human malignant lymphocytes induced by anti-IgM independent of B cell growth factor. J Immunol (1985) 0.78
Differential expression and serologically distinct subpopulations of human Ia antigens detected with monoclonal antibodies to Ia alpha and beta chains. Eur J Immunol (1982) 3.12
Cytokine gene polymorphism in human disease: on-line databases. Genes Immun (1999) 2.86
Interleukin 10 secretion in relation to human IL-10 locus haplotypes. Proc Natl Acad Sci U S A (1998) 2.18
Cytokine gene polymorphism in human disease: on-line databases, supplement 1. Genes Immun (2001) 1.94
Human interferon lambda-1 (IFN-lambda1/IL-29) modulates the Th1/Th2 response. Genes Immun (2007) 1.60
Modification of the hydroxy lactone ring of camptothecin: inhibition of mammalian topoisomerase I and biological activity. J Med Chem (1989) 1.57
Mapping of the human IL10 gene and further characterization of the 5' flanking sequence. Immunogenetics (1997) 1.49
Human MHC class II molecules as differentiation markers. Immunogenetics (1982) 1.45
Studies on the immunosuppressive properties of a pregnancy-associated alpha-macroglobulin. Clin Exp Immunol (1976) 1.45
Microsatellite alleles and single nucleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immun (1999) 1.32
Association between polymorphisms at the human IL-10 locus and systemic lupus erythematosus. Tissue Antigens (1997) 1.32
Cytokine gene polymorphism in human disease: on-line databases, supplement 2. Genes Immun (2002) 1.31
Preclinical warning of recrudescent mammary cancers by pregnancy-associated alpha-macroglobulin. Br J Surg (1976) 1.30
Monoclonal antibodies against HLA-DR antigens replace T helper cells in activation of B lymphocytes. Proc Natl Acad Sci U S A (1983) 1.28
Increased monocyte cytokine production in association with systemic complications in acute pancreatitis. Br J Surg (1996) 1.28
Synthesis of water-soluble (aminoalkyl)camptothecin analogues: inhibition of topoisomerase I and antitumor activity. J Med Chem (1991) 1.28
Immunohistochemical staining of non-Hodgkin's lymphoma with monoclonal antibodies specific for the leucocyte common antigen. J Pathol (1985) 1.26
Modulation of the human cytokine response by interferon lambda-1 (IFN-lambda1/IL-29). Genes Immun (2006) 1.24
MHC restriction of the antibody repertoire to secretory antigens, and a major allergen, of the nematode parasite Ascaris. J Immunol (1989) 1.18
A polymorphic dinucleotide repeat in the human IL-10 promoter. Immunogenetics (1995) 1.17
Synthesis of a pregnancy-associated alpha-macroglobulin by human leucocytes. Experientia (1975) 1.16
Forms and functions of CD44. Immunology (1998) 1.15
Immune complexes and diabetic microangiopathy. J Clin Lab Immunol (1978) 1.15
An immunoassay for a pregnancy-associated alpha-macroglobulin using antibody-enzyme conjugates. FEBS Lett (1974) 1.15
Correlation of lysosomal enzyme abnormalities in various forms of adult leukaemia. J Clin Pathol (1983) 1.14
Interferon lambda-1 (IFN-lambda1/IL-29) induces ELR(-) CXC chemokine mRNA in human peripheral blood mononuclear cells, in an IFN-gamma-independent manner. Genes Immun (2007) 1.14
Oestrogen receptors in macrophages. Scand J Immunol (1990) 1.13
Transplantation--nature's success. Lancet (1972) 1.11
Sequential expression of transforming growth factors alpha and beta 1 by eosinophils during cutaneous wound healing in the hamster. Am J Pathol (1993) 1.08
Xenoantisera against lymphoid cells: specificity and use in monitoring purification of mouse and human histocompatibility antigens. Tissue Antigens (1973) 1.08
Metabolites of methyl 5(6)-butyl-2-benzimidazolecarbamate (parbendazole). Structure and synthesis. J Med Chem (1973) 1.08
Aluminium lactate treatment of DQ12 quartz inhibits its ability to cause inflammation, chemokine expression, and nuclear factor-kappaB activation. Toxicol Appl Pharmacol (2001) 1.07
Immunophenotype analysis of malignant histiocytosis of the intestine. J Clin Pathol (1986) 1.07
Variations in the serum concentration of a human pregnancy-associated alpha-macroglobulin during pregnancy and after delivery. J Reprod Fertil (1975) 1.07
Correlation of the blood-level of a pregnancy-associated alpha-macroglobulin with the clinical course of cancer patients. Lancet (1975) 1.06
The induction of protective immunity to Leishmania major in the BALB/c mouse by interleukin 4 treatment. Eur J Immunol (1989) 1.05
Human antibodies to ovarian cancer antigens secreted by lymphoblastoid cell lines. J Clin Lab Immunol (1987) 1.05
Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma. Br J Cancer (1986) 1.05
Rapid naming deficits in children and adolescents with reading disabilities and attention deficit hyperactivity disorder. Brain Lang (2000) 1.05
Variations in the level of a pregnancy-associated alpha-macroglobulin in patients with cancer. J Clin Pathol (1975) 1.04
Immune complexes in newly diagnosed insulin-dependent (type I) diabetics. J Clin Lab Immunol (1978) 1.04
Interleukin-10 microsatellite polymorphisms and IL-10 locus alleles in rheumatoid arthritis susceptibility. Lancet (1998) 1.04
4-[2-(Di-n-propylamino)ethyl]-2(3H)-indolone: a prejunctional dopamine receptor agonist. J Med Chem (1985) 1.03
Enhanced expression of human Ia antigens by chronic lymphocytic leukemia cells following treatment with 12-O-tetradecanoylphorbol-13-acetate. Eur J Immunol (1983) 1.03
Studies of thyroglobulin autoantibody synthesis using a micro-ELISA assay. Immunol Lett (1982) 1.02
Identification of an immunosuppressive factor in pregnancy serum. Obstet Gynecol (1976) 1.01
A second polymorphic dinucleotide repeat in the 5' flanking region of the human IL10 gene. Immunogenetics (1996) 1.00
T-cell proliferation and expression of MHC class II antigens. Scand J Immunol (1984) 1.00
Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent. Parasite Immunol (1992) 0.99
Production and characterization of monoclonal antibodies with therapeutic potential against Shiga toxin. J Clin Lab Immunol (1990) 0.99
Identification of pregnancy-associated alpha-macroglobulin on the surface of peripheral blood leucocyte populations. Clin Exp Immunol (1977) 0.98
The specificity of the antibody response to internal antigens of Ascaris: heterogeneity in infected humans, and MHC (H-2) control of the repertoire in mice. Clin Exp Immunol (1990) 0.98
A biochemical approach to the staging of human breast cancer. Cancer (1977) 0.98
Analysis of genetic polymorphisms at the interleukin-10 and tumour necrosis factor loci in early-onset periodontitis. J Periodontal Res (1999) 0.96
Oestrogen-induced immunoregulation mediated through the thymus. J Clin Lab Immunol (1980) 0.96
Insertion of SMRV-H viral DNA at the c-myc gene locus of a BL cell line and presence in established cell lines. Int J Cancer (1992) 0.96
Pyrrolo[1,4]benzodiazepine antitumor antibiotics: relationship of DNA alkylation and sequence specificity to the biological activity of natural and synthetic compounds. Chem Res Toxicol (1992) 0.95
A non-conservative, coding single-nucleotide polymorphism in the N-terminal region of lactoferrin is associated with aggressive periodontitis in an African-American, but not a Caucasian population. Genes Immun (2005) 0.95
Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas. J Pathol (1985) 0.94
Pregnancy-associated beta 1-macroglobulin: detection on the surface of ovarian cancer cell lines. Int J Cancer (1985) 0.94
Identification and characterization of multiple splice forms of the human interleukin-23 receptor alpha chain in mitogen-activated leukocytes. Genes Immun (2008) 0.93
Immuno-localisation of tumour necrosis factor and its receptors in temporal arteritis. Rheumatol Int (1997) 0.93
T-cell lymphoma: morphology, immunophenotype and clinical features. Histopathology (1988) 0.93
Establishment of a karyotypically normal B-chronic lymphocytic leukemia cell line; evidence of leukemic origin by immunoglobulin gene rearrangement. Leuk Res (1990) 0.92
Are pregnancy-associated serum proteins responsible for the inhibition of lymphocyte transformation by pregnancy serum? Clin Exp Immunol (1980) 0.92
T-cell lymphoma in children and young adults: clinical, immunological and pathological features. Br J Cancer (1980) 0.90
Expression of MHC class II antigens in human B-cell leukaemia, and increased levels of class II antigens and DR-specific mRNA after stimulation with 12-O-tetradecanoyl phorbol-13-acetate. Immunology (1986) 0.90
Detection of mammary micrometastases by pregnancy-associated alpha 2-glycoprotein (PAG, alpha 2-PAG or PAM) and carcinoembryonic antigen (CEA). Eur J Cancer (1979) 0.90
Effects of steroids on the secretion of immunoregulatory factors by thymic epithelial cell cultures. Immunology (1981) 0.90
IL-10 and its homologs: important immune mediators and emerging immunotherapeutic targets. Trends Immunol (2001) 0.89
MHC class II (I-A) region control of the IgE antibody repertoire to the ABA-1 allergen of the nematode Ascaris. Immunology (1991) 0.89
Serum biochemical markers in lung cancer. Br J Cancer (1978) 0.89
Protein markers in disease (2). Pregnancy-associated alpha2-glycoprotein and cancer. J R Coll Surg Edinb (1978) 0.89
Antimicrobial susceptibility patterns in Pseudomonas aeruginosa: data from a multicenter Intensive Care Unit Surveillance Study (ISS) in the United States. J Chemother (2004) 0.88
Letter: Rosetting cells in autoimmune haemolytic anaemia. Lancet (1974) 0.88
Structure and expression of a tandem gene pair in Leishmania donovani that encodes a protein structurally homologous to eucaryotic cation-transporting ATPases. Mol Cell Biol (1987) 0.88
Persistent depletion of I kappa B alpha and interleukin-8 expression in human pulmonary epithelial cells exposed to quartz particles. Toxicol Appl Pharmacol (2000) 0.87
The effects of nandrolone, testosterone and their decanoate esters on murine lupus. Clin Exp Immunol (1981) 0.87
The human bladder carcinoma line T-24 secretes a human B-cell differentiation factor. Immunology (1987) 0.87
Identification of the major Ascaris allergen and its purification to homogeneity by high-performance liquid chromatography. Mol Biochem Parasitol (1990) 0.87
Oral involvement in mucous membrane pemphigoid. Clin Dermatol (1987) 0.87
Selective use of older adults in right lobe living donor liver transplantation. Am J Transplant (2007) 0.87
Letter: Immunosuppressive effect of pregnancy-associated alpha2-macroglobulin. Lancet (1975) 0.86
Interleukin-6 enhances the induction of human lymphokine-activated killer cells. Cancer Immunol Immunother (1990) 0.86
Biochemical variation of human Ia like antigens detected with monoclonal antibodies. Clin Exp Immunol (1983) 0.86
Karyotypic abnormalities and immunoglobulin gene rearrangements in Hodgkin's disease. Cancer Genet Cytogenet (1991) 0.86
Studies on the maternal immune response to placental antigens: absence of a blocking factor from the blood of abortion-prone women. Br J Obstet Gynaecol (1979) 0.86
A polymorphic microsatellite marker in the human p55 TNF receptor, CD120a. Genes Immun (2000) 0.85
The effect of Corynebacterium parvum therapy on immunoglobulin class and IgG subclass levels in cancer patients. Br J Cancer (1975) 0.85
Comparison of the effects of human pregnancy serum and anti-inflammatory compounds on the release of lysosomal enzymes from macrophages. Br J Exp Pathol (1977) 0.85
Letter: Mixed receptors. Lancet (1974) 0.85
The correlation between insulin antibodies and circulating immune complexes in diabetics with and without microangiopathy. Clin Exp Immunol (1983) 0.85
Passive enhancement of mouse skin allografts. Specificity of the antiserum for major histocompatibility. Transplantation (1974) 0.85
M4HS2, a new human T-cell line for the efficient generation of human T-cell hybrids. J Immunol Methods (1986) 0.85